Nuvectra Corporation (NASDAQ:NVTR) will be issuing its quarterly earnings data after the market closes on Tuesday, August 8th. Analysts expect the company to announce earnings of ($1.19) per share for the quarter.

Nuvectra Corporation (NASDAQ:NVTR) last released its quarterly earnings data on Tuesday, May 9th. The company reported ($1.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.25) by $0.02. Nuvectra Corporation had a negative net margin of 286.26% and a negative return on equity of 47.33%. The business had revenue of $5 million during the quarter, compared to analyst estimates of $4.61 million. During the same period in the previous year, the firm posted ($0.70) EPS. The firm’s revenue for the quarter was up 47.1% on a year-over-year basis. On average, analysts expect Nuvectra Corporation to post $-4.72 EPS for the current fiscal year and $-3.78 EPS for the next fiscal year.

Shares of Nuvectra Corporation (NVTR) opened at 12.08 on Monday. Nuvectra Corporation has a 1-year low of $4.63 and a 1-year high of $15.00. The firm’s market cap is $124.93 million. The company has a 50 day moving average of $12.60 and a 200 day moving average of $8.97.

TRADEMARK VIOLATION NOTICE: “Nuvectra Corporation (NVTR) to Release Quarterly Earnings on Tuesday” was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/07/nuvectra-corporation-nvtr-to-release-quarterly-earnings-on-tuesday.html.

In other news, CEO Scott F. Drees purchased 2,605 shares of the business’s stock in a transaction on Thursday, May 25th. The stock was purchased at an average price of $9.92 per share, for a total transaction of $25,841.60. Following the completion of the purchase, the chief executive officer now directly owns 90,041 shares in the company, valued at approximately $893,206.72. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Scott F. Drees purchased 7,395 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was purchased at an average price of $10.41 per share, with a total value of $76,981.95. Following the purchase, the chief executive officer now owns 99,136 shares of the company’s stock, valued at $1,032,005.76. The disclosure for this purchase can be found here.

Several brokerages recently commented on NVTR. ValuEngine upgraded shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a report on Friday, June 16th. B. Riley restated a “buy” rating and set a $12.00 target price on shares of Nuvectra Corporation in a report on Monday, May 15th. Piper Jaffray Companies restated a “neutral” rating and set a $14.00 target price on shares of Nuvectra Corporation in a report on Thursday, July 6th. TheStreet upgraded shares of Nuvectra Corporation from a “d” rating to a “c-” rating in a report on Monday, June 19th. Finally, Zacks Investment Research upgraded shares of Nuvectra Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, May 30th. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Nuvectra Corporation currently has an average rating of “Hold” and a consensus price target of $10.50.

Nuvectra Corporation Company Profile

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

Earnings History for Nuvectra Corporation (NASDAQ:NVTR)

Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.